By McKinsey & Company
McKinsey’s Biotech Innovation Index assesses innovation and funding in terms of four indicators: discovery (measured in numbers of patents and publications); translation (measured in numbers of new biotech companies and average amounts raised in early-stage financing); growth capital (measured in average amounts raised during late-stage funding and by IPOs and follow-on offerings on public markets); and impact (measured in numbers of products launched).
